Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank19
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P19
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -115.14% |
| Q2 2025 | 10.93% |
| Q1 2025 | 45.40% |
| Q4 2024 | -638.62% |
| Q3 2024 | 133.63% |
| Q2 2024 | 36.85% |
| Q1 2024 | 11.06% |
| Q4 2023 | -30.26% |
| Q3 2023 | -20.49% |
| Q2 2023 | -2.03% |
| Q1 2023 | 60.15% |
| Q4 2022 | 44.17% |
| Q3 2022 | -22.94% |
| Q2 2022 | -741.02% |
| Q1 2022 | 90.52% |
| Q4 2021 | 41.52% |
| Q3 2021 | -1734.60% |
| Q2 2021 | -3.06% |
| Q1 2021 | -524.18% |
| Q4 2020 | -86.37% |
| Q3 2020 | 322.93% |
| Q2 2020 | 31.15% |
| Q1 2020 | 22.40% |
| Q4 2019 | -369.25% |
| Q3 2019 | -43.92% |
| Q2 2019 | 12.56% |
| Q1 2019 | 7.29% |
| Q4 2018 | 25.20% |
| Q3 2018 | 39.16% |
| Q2 2018 | 2.23% |
| Q1 2018 | 1650.28% |
| Q4 2017 | -423.86% |
| Q3 2017 | 0.00% |